SAGE-217 reduces depressive symptoms in patients with major depression within 2 weeks
1. Patients with major depression randomized to receive SAGE-217, a positive allosteric modulator of γ-aminobutyric acid (GABA) type A receptors,...
Dayton is an MD Candidate at Harvard Medical School. Originally from Wyoming, he attended Colorado State University where he completed degrees in environmental health and health physics. Subsequently, he spent one year at the NCI conducting research on medical radiation dosimetry. Academic interests include machine learning and artificial intelligence in medicine, and enjoys learning about the applicability of these subjects towards other industries and businesses. In his free time he enjoys making beef jerky, working out, and reading books on historical figures.
1. Patients with major depression randomized to receive SAGE-217, a positive allosteric modulator of γ-aminobutyric acid (GABA) type A receptors,...
1. In patients with primary varicose veins followed for 5 years after treatment, those randomized to receive laser ablation or...
1. In patients with pulmonary alveolar proteinosis, use of twice daily inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) did not improve clinical...
1. Patients hospitalized with acute heart failure (AHF) randomized to receive the vasodilator serelaxin experienced similar occurrence of death from...
1. For previously untreated HIV-1 patients in Cameroon, treatment with dolutegravir was noninferior to low dose efavirenz at lowering viral...
1. Approximately a quarter of multiple myeloma patients that had refractory disease despite treatment with a proteasome inhibitor, immunomodulatory agent,...
1. Over a median period of almost 16 months, type 2 diabetic (T2DM) patients randomized to oral semaglutide for experienced...
1. In this randomized control trial of neuromyelitis optica spectrum disorder (NMOSD) patients with aquaporin-4 antibodies (AQP4-IgG), those randomized to...
1. In relatives of patients with type 1 diabetes (T1DM) at risk for disease development, randomization to teplizumab delayed time...
1. In children with type 2 diabetes (T2DM) on metformin, those randomized to liraglutide had better glycemic control after 26...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.